About BioAscent
BioAscent is a company based in Motherwell (United Kingdom) founded in 2013.. BioAscent has raised $3.7 million across 3 funding rounds from investors including Maven Capital Partners. The company has 41 employees as of January 31, 2020. BioAscent offers products and services including Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry. BioAscent operates in a competitive market with competitors including McKesson, Resilience, Entero Healthcare, Zhejiang Mingdu Zhikong Technology and ASP Isotopes, among others.
- Headquarter Motherwell, United Kingdom
- Employees 41 as on 31 Jan, 2020
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioascent Discovery Limited
- Date of Incorporation 15 Feb, 2013
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.7 M (USD)
in 3 rounds
-
Latest Funding Round
$3.7 M (USD), Seed
Jun 20, 2018
- Investors
-
Employee Count
41
as on Jan 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAscent
BioAscent offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Comprehensive projects for developing new drugs
Design and synthesis of chemical compounds
High-throughput testing of potential drug candidates
Data analysis to accelerate drug design processes
Unlock access to complete
Unlock access to complete
Funding Insights of BioAscent
BioAscent has successfully raised a total of $3.7M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3.7 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $3.7M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Seed - BioAscent | Valuation |
investors |
|
| Mar, 2014 | Amount | Seed - BioAscent | Valuation |
investors |
|
| Nov, 2013 | Amount | Seed - BioAscent | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioAscent
BioAscent has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Maven Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioAscent
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioAscent
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioascent Comparisons
Competitors of BioAscent
BioAscent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Resilience, Entero Healthcare, Zhejiang Mingdu Zhikong Technology and ASP Isotopes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Products and services are provided in the healthcare industry.
|
|
| domain | founded_year | HQ Location |
Supply chain services for biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
India's leading healthcare products distribution platform
|
|
| domain | founded_year | HQ Location |
AI-based logistics services are provided in Hangzhou, China.
|
|
| domain | founded_year | HQ Location |
Supply chain solution services for isotope production are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioascent
Frequently Asked Questions about BioAscent
When was BioAscent founded?
BioAscent was founded in 2013.
Where is BioAscent located?
BioAscent is headquartered in Motherwell, United Kingdom. It is registered at Motherwell, Scotland, United Kingdom.
Is BioAscent a funded company?
BioAscent is a funded company, having raised a total of $3.7M across 3 funding rounds to date.
How many employees does BioAscent have?
As of Jan 31, 2020, the latest employee count at BioAscent is 41.
What does BioAscent do?
BioAscent was established in 2013 in Motherwell, United Kingdom, focusing on compound management within the drug discovery sector. Services provided include compound management, Compound Cloud, compound collection sharing, and disaster recovery. Operations are conducted from a former automated facility of Merck. A confidential partner-matching service is facilitated to enable sharing of compound collections with pharmaceutical, biotechnology, and academic institutions under owner-specified terms.
Who are the top competitors of BioAscent?
BioAscent's top competitors include Entero Healthcare, McKesson and Resilience.
What products or services does BioAscent offer?
BioAscent offers Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry.
Who are BioAscent's investors?
BioAscent has 1 investor. Key investors include Maven Capital Partners.
What is BioAscent's valuation?
The valuation of BioAscent is $4.22M as of Jun 2018.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.